These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 24117026)

  • 1. Myasthenia gravis: an update for the clinician.
    Sieb JP
    Clin Exp Immunol; 2014 Mar; 175(3):408-18. PubMed ID: 24117026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance immunosuppression in myasthenia gravis, an update.
    Morren J; Li Y
    J Neurol Sci; 2020 Mar; 410():116648. PubMed ID: 31901719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis: subgroup classification and therapeutic strategies.
    Gilhus NE; Verschuuren JJ
    Lancet Neurol; 2015 Oct; 14(10):1023-36. PubMed ID: 26376969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia.
    van Sonderen A; Wirtz PW; Verschuuren JJ; Titulaer MJ
    Curr Treat Options Neurol; 2013 Apr; 15(2):224-39. PubMed ID: 23263888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance immunosuppression in myasthenia gravis.
    Gotterer L; Li Y
    J Neurol Sci; 2016 Oct; 369():294-302. PubMed ID: 27653912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future standards in treatment of myasthenia gravis.
    Gold R; Schneider-Gold C
    Neurotherapeutics; 2008 Oct; 5(4):535-41. PubMed ID: 19019304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis and congenital myasthenic syndromes.
    Gilhus NE
    Handb Clin Neurol; 2023; 195():635-652. PubMed ID: 37562891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia and the neuromuscular junction.
    Gilhus NE
    Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline for the management of myasthenic syndromes.
    Wiendl H; Abicht A; Chan A; Della Marina A; Hagenacker T; Hekmat K; Hoffmann S; Hoffmann HS; Jander S; Keller C; Marx A; Melms A; Melzer N; Müller-Felber W; Pawlitzki M; Rückert JC; Schneider-Gold C; Schoser B; Schreiner B; Schroeter M; Schubert B; Sieb JP; Zimprich F; Meisel A
    Ther Adv Neurol Disord; 2023; 16():17562864231213240. PubMed ID: 38152089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and clinical classification of autoimmune myasthenia gravis.
    Berrih-Aknin S; Frenkian-Cuvelier M; Eymard B
    J Autoimmun; 2014; 48-49():143-8. PubMed ID: 24530233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis: options and timing of immunomodulatory treatment.
    Spring PJ; Spies JM
    BioDrugs; 2001; 15(3):173-83. PubMed ID: 11437683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic myasthenia gravis: immunological and clinical aspects.
    Skeie GO; Romi F
    Eur J Neurol; 2008 Oct; 15(10):1029-33. PubMed ID: 18717725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment.
    Gilhus NE; Andersen H; Andersen LK; Boldingh M; Laakso S; Leopoldsdottir MO; Madsen S; Piehl F; Popperud TH; Punga AR; Schirakow L; Vissing J
    Eur J Neurol; 2024 May; 31(5):e16229. PubMed ID: 38321574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the treatment of myasthenia gravis.
    Gold R; Hohlfeld R; Toyka KV
    Ther Adv Neurol Disord; 2008 Sep; 1(2):36-51. PubMed ID: 21180568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis.
    Silvestri NJ; Wolfe GI
    Semin Neurol; 2012 Jul; 32(3):215-26. PubMed ID: 23117946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myasthenia gravis: current status of antibody diagnostics and aspects on refractory myasthenia gravis].
    Wenninger S; Schoser B
    Fortschr Neurol Psychiatr; 2018 Sep; 86(9):551-558. PubMed ID: 30248688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis-Pathophysiology, diagnosis, and treatment.
    Tannemaat MR; Huijbers MG; Verschuuren JJGM
    Handb Clin Neurol; 2024; 200():283-305. PubMed ID: 38494283
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.